3645 results for «809»

Filter By

3645 results

Clinical experience with transcatheter tricuspid valve replacement

19 May 2026 – From EuroPCR 2026

This session shares clinical experience with transcatheter tricuspid valve replacement (TTVR) for severe tricuspid regurgitation. It includes outcomes after prior repair, analysis of stent frame geometry as a predictor of leaflet abnormalities, and assessments of functional and quality-of-life improvements with systems such as Evoque and MonarQ....

PCR's Got Talent Round 1 - Session 1

19 May 2026 – From EuroPCR 2026

This dynamic session from PCR's Got Talent Round 1 presents a diverse array of cutting-edge research and clinical findings. Topics include the influence of local and systemic inflammation on PCI outcomes, adherence to OCT-guided PCI metrics, comparative guidance strategies using angiography-derived FFR and IVUS, and the...

AI fundamentals for busy cardiologists: opportunities, limitations and safe use

19 May 2026 – From EuroPCR 2026

Designed for busy cardiologists, this session elucidates the fundamentals of artificial intelligence relevant to cardiology practice. It covers the main AI tool families, including large language models and computer vision, and emphasizes effective and safe prompting techniques for clinical and academic use. Attendees will also learn...

Structural and valvular innovations

19 May 2026 – From EuroPCR 2026

This session highlights the latest innovations in structural and valvular cardiology, featuring novel technologies such as a new self-expandable transcatheter aortic valve for aortic stenosis treatment and a temporary atrioventricular sequential pacing system. It also discusses non-clinical testing methodologies supporting U.S. market approvals, non-invasive ultrasound therapy...

Innovations in vascular therapies

19 May 2026 – From EuroPCR 2026

Discover cutting-edge innovations in vascular therapies highlighting novel technologies such as Pulse Intravascular Lithotripsy (IVL) for calcium modification and Amplitude Vascular Systems. The session also presents drug-free restenosis control strategies via CD31 camouflage coating promoting physiological-grade healing, emphasizing emerging solutions aimed at improving vascular intervention outcomes.

Aortic paravalvular leak unmasked: different faces, different strategies

19 May 2026 – From EuroPCR 2026

Examine diverse clinical scenarios and management strategies for aortic paravalvular leaks (PVL), including complex percutaneous closures post-TAVI and surgical interventions. This session presents challenging cases demonstrating varied presentations and approaches such as mechanical valve loop utilization, highlighting the complexities and tailored solutions required for successful PVL...

RESIL-Card in action: early European experience and lessons from the first users

19 May 2026 – From EuroPCR 2026

This session presents the early European experience with the RESIL-Card tool, designed to optimize interventional cardiology care pathways during crises. It includes practical insights from early adopters, updates on dissemination efforts across Europe, strategies for engaging patients and organizations, and discussions on national and EU political...

TAVI procedural complications - Part 2: devices issues, access-related complications and more

19 May 2026 – From EuroPCR 2026

Delve into procedural challenges encountered during TAVI, focusing on device-related issues, access complications, and bailout strategies. This session reviews real-world cases such as balloon retention, valve expansion failure, TAV-in-TAV interventions, and transcaval access lessons, providing critical insights to manage and mitigate procedural complications effectively.

What bench testing teaches us about real world PCI

19 May 2026 – From EuroPCR 2026

This session explores bench testing insights into real-world percutaneous coronary interventions (PCI). Topics include comparative expansion ratios of coronary stents, prognostic assessments after drug-coated balloon treatments, mechanical performance of magnesium scaffolds in bifurcations, preclinical safety and computational modeling of bioresorbable polymer-coated stents, and evaluations of commonly...

Complex PCI in patients with acute coronary syndrome

19 May 2026 – From EuroPCR 2026

Explore complex PCI management in acute coronary syndrome patients through detailed case presentations illustrating complication handling and bailout techniques. Learn from challenging scenarios including graft perforation, no-flow situations, guidewire dissections, and stent dislodgement, emphasizing preparedness and strategic responses to improve clinical outcomes in high-risk interventions.

Complication management in CTO PCI - Part 1

19 May 2026 – From EuroPCR 2026

This session addresses complication management during chronic total occlusion (CTO) percutaneous coronary interventions. It covers strategies for unexpected coronary complications, managing tamponade without visible perforation, rescue techniques for atherectomy-related perforations, managing dry pericardial tamponade after septal branch perforation, and challenges when retrograde approaches encounter thrombosis in...

CTO PCI: technical developments

19 May 2026 – From EuroPCR 2026

This session highlights technical developments in CTO PCI, featuring comparative insights from the ONUBA-CTO study on retrograde versus antegrade approaches, sex-based differences in long-term outcomes, management of balloon-undilatable lesions, the role of virtual reality audiovisual distraction, the impact of core laboratory feedback with OCT, and contemporary...

Best complications in primary PCI

19 May 2026 – From EuroPCR 2026

This session delves into a spectrum of challenging complications encountered during primary PCI, showcasing advanced management techniques and unique case scenarios. Highlights include managing complex cathlab nightmares, innovative IVUS-guided true lumen re-entry strategies, and critical decision-making in coronary artery dissections.

Novel Hertz Contact intravascular lithotripsy: calcium fragmentation with zero trade-offs

27 Feb 2026 – From Euro4C Annual Meeting

This session introduces the novel Hertz Contact intravascular lithotripsy system, designed for effective calcium fragmentation without trade-offs. It covers lesion types amenable to treatment, system mechanism, optimization tips, and discusses real-world cases along with supporting clinical trial evidence.

Novel Hertz Contact intravascular lithotripsy: calcium fragmentation with zero trade-offs

Introducing the next era of coronary intravascular lithotripsy: an aero-volution in calcium modification

27 Feb 2026 – From Euro4C Annual Meeting

Explore the next era of coronary intravascular lithotripsy featuring innovative technology for calcium modification. This session covers the unique mechanism of action, practical application in complex cases, and recent clinical evidence supporting its safety and efficacy.

Introducing next era of coronary intravascular lithotripsy: aero-volution in calcium modification

Mastering techniques from basic to complex - Tricuspid TEER fundamentals

13 Feb 2026 – From PCR Tokyo Valves 2026

Gain foundational knowledge in tricuspid TEER by understanding anatomical criteria for patient suitability, key procedural steps, and device techniques, enhanced by simulation-based procedural training.

Mastering techniques from basic to complex - Tricuspid TEER fundamentals

Patient selection for tricuspid TEER in 2026

14 Feb 2026 – From PCR Tokyo Valves 2026

This session focuses on optimizing patient selection for tricuspid transcatheter edge-to-edge repair (TEER) in 2026. It integrates anatomical, haemodynamic, and clinical criteria to identify ideal candidates, explores evolving treatment boundaries between TEER, transcatheter tricuspid valve replacement (TTVR), and medical management, and applies evidence from key trials...

Patient selection for tricuspid TEER in 2026

Getting ready for tricuspid TEER: key steps in building a successful programme

14 Feb 2026 – From PCR Tokyo Valves 2026

Prepare to establish a successful tricuspid TEER programme by understanding essential components such as systematic echocardiographic and clinical assessments for patient selection, procedural fundamentals, and programme development supported by clinical evidence.

Getting ready for tricuspid TEER: key steps in building a successful programme

Assessment of vasomotor coronary disorders in the cathlab

20 May 2026 – From EuroPCR 2026

This session focuses on the invasive assessment of vasomotor coronary disorders within the catheterization laboratory. It reviews clinical profiles, endothelial function evaluation using acetylcholine and advanced hemodynamic methods, coronary volume analysis, and refined classification of coronary spasm, enhancing diagnostic accuracy in patients with suspected ischemia and...

Management of calcified lesions in challenging scenarios

20 May 2026 – From EuroPCR 2026

This session presents complex cases involving calcified coronary lesions in challenging clinical scenarios including STEMI, bifurcation lesions, tortuosity, and concurrent TAVI procedures. It demonstrates integrative strategies such as rota-lithotripsy and addresses decision-making processes in managing calcification beyond the coronaries to optimize patient outcomes.

Didn’t find what you were looking for?